Furthermore, it has the ability to control the activation of immune-related genes, influence the effectiveness of anti-PD-1 immunotherapy, and facilitate the programmed cell death of tumor cells through the regulation of GSDMC/caspase-8 [29, 30]. Here, PDCD1 is linked to neoplasm.